카르무스틴

카르무스틴
카르무스틴 구조식 이미지
카스 번호:
154-93-8
한글명:
카르무스틴
동의어(한글):
비스클로로에틸니트로소우레아;카르무스틴;카무스틴
상품명:
Carmustine
동의어(영문):
BCNU;BCUN;BICNU;fda0345;DTI 015;Gliadel;sri1720;sk27702;BECENUN;nitrumon
CBNumber:
CB0449612
분자식:
C5H9Cl2N3O2
포뮬러 무게:
214.05
MOL 파일:
154-93-8.mol
MSDS 파일:
SDS

카르무스틴 속성

녹는점
30 °C (lit.)
밀도
1.6948 (rough estimate)
굴절률
1.6100 (estimate)
저장 조건
-20°C
용해도
insoluble in H2O; ≥21.51 mg/mL in DMSO; ≥27.15 mg/mL in EtOH
물리적 상태
(유성 액체에서 무정형 고체로)
산도 계수 (pKa)
10.19±0.46(Predicted)
색상
담황색 분말
수용성
18°C에서 <0.1g/100mL
Merck
14,1845
Henry's Law Constant
2.1×105 mol/(m3Pa) at 25℃, HSDB (2015)
안정성
온도에 민감함
InChI
1S/C5H9Cl2N3O2/c6-1-3-8-5(11)10(9-12)4-2-7/h1-4H2,(H,8,11)
InChIKey
DLGOEMSEDOSKAD-UHFFFAOYSA-N
SMILES
ClCCNC(=O)N(CCCl)N=O
CAS 데이터베이스
154-93-8(CAS DataBase Reference)
IARC
2A (Vol. 26, Sup 7) 1987
EPA
1,3-Bis(2-chloroethyl)-1-nitrosourea (154-93-8)
안전
  • 위험 및 안전 성명
  • 위험 및 사전주의 사항 (GHS)
위험품 표기 T+
위험 카페고리 넘버 45-46-60-61-28
안전지침서 53-22-36/37/39-45
유엔번호(UN No.) 3249
WGK 독일 3
RTECS 번호 YS2625000
위험 등급 6.1(a)
포장분류 II
HS 번호 29241990
스토리지 클래스 6.1A - Combustible acute toxic Cat. 1 and 2
very toxic hazardous materials
Hazard Classifications Acute Tox. 2 Oral
Carc. 1B
Repr. 1B
유해 물질 데이터 154-93-8(Hazardous Substances Data)
독성 LD50 in mice (mg/kg): 19-25 orally, 26 i.p., 24 s.c.; in rats (mg/kg): 30-34 orally (Thompson, Larson)
중점관리물질 필터링 별표2-45
그림문자(GHS): Skull and Crossbones (GHS06)Health Hazard (GHS08)
신호 어: Danger
유해·위험 문구:
암호 유해·위험 문구 위험 등급 범주 신호 어 그림 문자 P- 코드
H300 삼키면 치명적임 급성 독성 물질 - 경구 구분 1,2 위험 P264, P270, P301+P310, P321, P330,P405, P501
H350 암을 일으킬 수 있음 (노출되어도 암을 일으키지 않는다는 결정적인 증거가 있는 노출경로가 있다면 노출경로 기재) 발암성 물질 구분 1A, 1B 위험
H360 태아 또는 생식능력에 손상을 일으킬 수 있음 생식독성 물질 구분 1A, 1B 위험
예방조치문구:
P201 사용 전 취급 설명서를 확보하시오.
P280 보호장갑/보호의/보안경/안면보호구를 착용하시오.
P308+P313 노출 또는 접촉이 우려되면 의학적인 조치· 조언를 구하시오.
NFPA 704
0
3 0

카르무스틴 MSDS


1,3-Bis(2-chloroethyl)-1-nitrosourea

카르무스틴 C화학적 특성, 용도, 생산

개요

Carmustine is a nitrogen mustard β-chloro-nitrosourea compound that is used as an alkylating agent. It forms interstrand crosslinks in DNA, which prevents DNA replication and transcription leading to apoptosis. Carmustine is also reported to inhibit glutathione reductase, thioredoxin reductase, and lipoamide dehydrogenase. Carmustine has been tested in clinical trials as a cytostatic agent for Hodgkin’s and non-Hodgkin’s lymphoma, myeloma, malignant melanoma, glioblastoma, and other brain tumors.

화학적 성질

Carmustine is an orange-yellow crystalline solid or powder.

용도

Carmustine is a nitrogen mustard β-chloro-nitrosourea compound that is used as an alkylating agent. It forms interstrand crosslinks in DNA, which prevents DNA replication and transcription leading to apoptosis. Carmustine is also reported to inhibit glutathione reductase, thioredoxin reductase, and lipoamide dehydrogenase. Carmustine has been tested in clinical trials as a cytostatic agent for Hodgkin’s and non-Hodgkin’s lymphoma, myeloma, malignant melanoma, glioblastoma, and other brain tumors.

정의

ChEBI: A member of the class of N-nitrosoureas that is 1,3-bis(2-chloroethyl)urea in which one of the nitrogens is substituted by a nitroso group.

일반 설명

Orange-yellow solid.

공기와 물의 반응

Insoluble in water.

반응 프로필

Carmustin decomposes rapidly in acid and in solutions above pH 7; most stable in petroleum ether or aqueous solution at pH 4.

위험도

Extremely toxic, central nervous system depression, pulmonary fibrosis, renal and hepatic damage, cytotoxic, immunosuppressive, carcino- gen.

화재위험

Flash point data for Carmustin are not available. Carmustin is probably combustible.

Safety Profile

Confirmed carcinogen withexperimental carcinogenic and tumorigenic data. A humanpoison by parenteral route. An experimental poison byingestion, intravenous, intraperitoneal, parenteral, andsubcutaneous routes. Human systemic effects byparenteral, int

잠재적 노출

BCNU has been used since 1971 as an antineoplastic agent in the treatment of Hodgkin’slymphoma; multiple meyloma; and primary or metastatic brain tumors. It also has been reported to have antiviral, antibacterial, and antifungal activity, but no evidence was found that it is used in these ways. BCNU is not known to be naturally occurring. Health professionals who handle this drug (for example, pharmacists, nurses, and physicians) may possibly be exposed to BCNU during drug preparation, administration, or cleanup; however, the risks can be avoided through use of containment equipment and proper work practices

Carcinogenicity

Bis(chloroethyl) nitrosourea (BCNU) is reasonably anticipated to be a human carcinogen based on sufficient evidence of carcinogenicity from studies in experimental animals.

환경귀착

It is generally assumed that BCNU exerts its cytotoxicity through the liberation of alkylating and carbamoylating moieties. An alkylating entity, particularly chloroethyl carbonium ion, is strongly electrophilic and can alkylate a variety of biomolecules, including the purine and pyrimidine bases of DNA. BCNU causes DNA interstrand cross-linking, which is associated with cytotoxicity. The carbamoylation of lysine residues of protein can inactivate certain enzymes, thus interfering with DNA and RNA synthesis and repair processes. The inhibition of glutathione reductase by this carbamoylation further contributes to cytotoxicity.

운송 방법

UN3249 Medicine, solid, toxic, n.o.s., Hazard Class: 6.1; Labels: 6.1-Poisonous materials. UN2811 Toxic solids, organic, n.o.s., Hazard Class: 6.1; Labels: 6.1- Poisonous materials, Technical Name Required.

비 호환성

Acids and acid solutions above pH 7 cause rapid decomposition. Most stable at pH 4 in aqueous solution or petroleum ether.

폐기물 처리

It is inappropriate and possibly dangerous to the environment to dispose of expired or waste pharmaceuticals by flushing them down the toilet or discarding them to the trash. Household quantities of expired or waste pharmaceuticals may be mixed with wet cat litter or coffee grounds, double-bagged in plastic, discard in trash. Larger quantities shall carefully take into consideration applicable DEA, EPA, and FDA regulations. If possible return the pharmaceutical to the manufacturer for proper disposal being careful to properly label and securely package the material. Alternatively, the waste pharmaceutical shall be labeled, securely packaged and transported by a state licensed medical waste contractor to dispose by burial in a licensed hazardous or toxic waste landfill or incinerator.

카르무스틴 준비 용품 및 원자재

원자재

준비 용품


카르무스틴 공급 업체

글로벌( 387)공급 업체
공급자 전화 이메일 국가 제품 수 이점
Changzhou green chemical co., LTD 0519-82733646 13814799543
sales_01@salutchem.com China 108 58
J & K SCIENTIFIC LTD. 18210857532 18210857532
jkinfo@jkchemical.com China 96815 76
3B Pharmachem (Wuhan) International Co.,Ltd. 18930552037
3bsc@sina.com China 15813 69
Chembest Research Laboratories Limited 021-20908456
sales@BioChemBest.com China 5996 61
TCI (Shanghai) Development Co., Ltd. 021-67121386
Sales-CN@TCIchemicals.com China 24512 81
Beijing HwrkChemical Technology Co., Ltd 89508211 18501085097
sales.bj@hwrkchemical.com China 9409 55
Pure Chemistry Scientific Inc. 001-857-928-2050 or 1-888-588-9418
sales@chemreagents.com United States 10174 62
Adamas Reagent, Ltd. 4006009262 13023226327
hmj@titansci.com China 14098 59
LGM Pharma 1-(800)-881-8210
inquiries@lgmpharma.com United States 2110 70
Chemsky(shanghai)International Co.,Ltd. 021-50135380
shchemsky@sina.com China 32273 50

카르무스틴 관련 검색:

Copyright 2019 © ChemicalBook. All rights reserved